Organon (OGN) Restructuring Costs (2020 - 2026)
Organon (OGN) posted quarterly Restructuring Costs of $31.0 million for Q1 2026, down 63.95% year-over-year from $86.0 million in Q1 2025, and up 342.86% on a QoQ basis from $7.0 million in Q4 2025.
Organon (OGN) Restructuring Costs (2020 - 2026) Analysis & Trends
Organon has reported Restructuring Costs for 7 years, with the latest figure at $31.0 million in Q1 2026.
- Restructuring Costs for Q1 2026 came in at $31.0 million, down 63.95% year-over-year; the trailing twelve-month figure through Jun 2026 was $38.0 million (down 60.42% YoY), and the FY2025 annual result was $95.0 million, up 206.45% from the prior year.
- Restructuring Costs rose to $31.0 million in Q1 2026, from $7.0 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $86.0 million in Q1 2025 and troughed at $2.0 million in Q2 2025.
- A 5-year average of $25.9 million and a median of $14.0 million in 2022 frame the typical range for Restructuring Costs.
- The widest annual swing landed in 2022, when Restructuring Costs jumped 1000.0%; it then slumped 88.57% in 2024.
- A 5-year view of Restructuring Costs shows it stood at $17.0 million in 2022, then soared by 311.76% to $70.0 million in 2023, then slumped by 88.57% to $8.0 million in 2024, then retreated by 12.5% to $7.0 million in 2025, then soared by 342.86% to $31.0 million in 2026.
- Per Business Quant data, the three most recent Restructuring Costs figures were $31.0 million in Q1 2026, $7.0 million in Q4 2025, and $2.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.85 Bn | 625.09 Bn | 17.26 Bn |
| 2 | AbbVie | 464.52 Bn | 457.95 Bn | 12.70 Bn |
| 3 | Merck | 371.03 Bn | 363.89 Bn | 12.21 Bn |
| 4 | Novartis Ag | 298.88 Bn | 291.19 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.79 Bn | 250.89 Bn | 12.86 Bn |
| 6 | Amgen | 234.78 Bn | 220.79 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 179.58 Bn | 176.40 Bn | 6.22 Bn |
| 8 | Pfizer | 159.12 Bn | 147.42 Bn | 10.94 Bn |
| 9 | Gsk | 104.71 Bn | 100.55 Bn | 8.24 Bn |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 86.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Mar 31, 2024 | 23.00 Mn |
| Dec 31, 2023 | 70.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 17.00 Mn |
| Sep 30, 2020 | 12.00 Mn |
| Jun 30, 2020 | 19.00 Mn |
| Mar 31, 2020 | 12.00 Mn |